(LASR) nLIGHT - Overview
Stock: Semiconductor Lasers, Fiber Lasers, Fiber Amplifiers, Beam
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 81.6% |
| Relative Tail Risk | -13.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.16 |
| Alpha | 295.72 |
| Character TTM | |
|---|---|
| Beta | 1.991 |
| Beta Downside | 2.133 |
| Drawdowns 3y | |
|---|---|
| Max DD | 59.01% |
| CAGR/Max DD | 0.93 |
Description: LASR nLIGHT January 16, 2026
nLIGHT, Inc. (NASDAQ: LASR) designs, develops, manufactures and sells semiconductor and fiber lasers for industrial machining, micro-fabrication, aerospace and defense. The business is split between a Laser Products segment (standard-issue semiconductor and programmable fiber lasers) and an Advanced Development segment that builds high-energy-laser (HEL) subsystems such as fiber amplifiers, beam-combination optics and control packages for directed-energy weapons.
In FY 2023 the company reported roughly $110 million in revenue, with the Laser Products line contributing about 68 % and the Advanced Development segment posting a 22 % YoY increase driven by new defense contracts in the U.S. and South Korea. The global industrial laser market is projected to grow at a 7 % CAGR through 2030, buoyed by rising automation, electric-vehicle battery manufacturing and semiconductor-fab demand-trends that directly expand nLIGHT’s addressable base. A key macro driver is sustained U.S. defense spending, which the Department of Defense has earmarked over $1 billion for directed-energy programs through FY 2027, providing a potential pipeline for nLIGHT’s high-energy offerings.
Investors should watch the company’s cash-conversion cycle and its ability to scale production of the 1-kW+ fiber lasers that are increasingly required for next-generation LiDAR and additive-manufacturing applications; a sustained improvement in gross margin above 35 % would be a strong catalyst. For a deeper, data-driven look at LASR’s valuation metrics and scenario analysis, see the ValueRay research hub-your next step in a disciplined assessment.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -43.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.03 > 0.02 and ΔFCF/TA -1.91 > 1.0 |
| NWC/Revenue: 82.56% < 20% (prev 86.00%; Δ -3.44% < -1%) |
| CFO/TA -0.00 > 3% & CFO -75.0k > Net Income -43.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 5.63 > 1.5 & < 3 |
| Outstanding Shares: last quarter (49.7m) vs 12m ago 3.17% < -2% |
| Gross Margin: 23.80% > 18% (prev 0.21%; Δ 2359 % > 0.5%) |
| Asset Turnover: 77.13% > 50% (prev 69.71%; Δ 7.42% > 0%) |
| Interest Coverage Ratio: -26.42 > 6 (EBITDA TTM -25.2m / Interest Expense TTM 1.53m) |
Altman Z'' -5.08
| A: 0.63 (Total Current Assets 228.4m - Total Current Liabilities 40.5m) / Total Assets 298.7m |
| B: -1.15 (Retained Earnings -343.7m / Total Assets 298.7m) |
| C: -0.14 (EBIT TTM -40.4m / Avg Total Assets 295.0m) |
| D: -4.32 (Book Value of Equity -346.7m / Total Liabilities 80.2m) |
| Altman-Z'' Score: -5.08 = D |
Beneish M -3.30
| DSRI: 1.09 (Receivables 49.3m/40.3m, Revenue 227.5m/203.1m) |
| GMI: 0.86 (GM 23.80% / 20.53%) |
| AQI: 0.73 (AQ_t 0.05 / AQ_t-1 0.07) |
| SGI: 1.12 (Revenue 227.5m / 203.1m) |
| TATA: -0.15 (NI -43.5m - CFO -75.0k) / TA 298.7m) |
| Beneish M-Score: -3.30 (Cap -4..+1) = AA |
What is the price of LASR shares?
Over the past week, the price has changed by -2.17%, over one month by +21.00%, over three months by +46.32% and over the past year by +310.78%.
Is LASR a buy, sell or hold?
- StrongBuy: 5
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the LASR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 47.4 | 2.9% |
| Analysts Target Price | 47.4 | 2.9% |
| ValueRay Target Price | 46.5 | 0.9% |
LASR Fundamental Data Overview February 03, 2026
P/S = 10.1806
P/B = 10.9501
Revenue TTM = 227.5m USD
EBIT TTM = -40.4m USD
EBITDA TTM = -25.2m USD
Long Term Debt = 20.0m USD (from longTermDebt, last quarter)
Short Term Debt = 2.31m USD (from shortTermDebt, last quarter)
Debt = 31.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -49.8m USD (from netDebt column, last quarter)
Enterprise Value = 2.23b USD (2.32b + Debt 31.3m - CCE 115.8m)
Interest Coverage Ratio = -26.42 (Ebit TTM -40.4m / Interest Expense TTM 1.53m)
EV/FCF = -220.1x (Enterprise Value 2.23b / FCF TTM -10.1m)
FCF Yield = -0.45% (FCF TTM -10.1m / Enterprise Value 2.23b)
FCF Margin = -4.46% (FCF TTM -10.1m / Revenue TTM 227.5m)
Net Margin = -19.13% (Net Income TTM -43.5m / Revenue TTM 227.5m)
Gross Margin = 23.80% ((Revenue TTM 227.5m - Cost of Revenue TTM 173.4m) / Revenue TTM)
Gross Margin QoQ = 31.09% (prev 29.90%)
Tobins Q-Ratio = 7.47 (Enterprise Value 2.23b / Total Assets 298.7m)
Interest Expense / Debt = 3.64% (Interest Expense 1.14m / Debt 31.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = -31.9m (EBIT -40.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 5.63 (Total Current Assets 228.4m / Total Current Liabilities 40.5m)
Debt / Equity = 0.14 (Debt 31.3m / totalStockholderEquity, last quarter 218.5m)
Debt / EBITDA = 1.98 (negative EBITDA) (Net Debt -49.8m / EBITDA -25.2m)
Debt / FCF = 4.91 (negative FCF - burning cash) (Net Debt -49.8m / FCF TTM -10.1m)
Total Stockholder Equity = 215.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.75% (Net Income -43.5m / Total Assets 298.7m)
RoE = -20.16% (Net Income TTM -43.5m / Total Stockholder Equity 215.9m)
RoCE = -17.12% (EBIT -40.4m / Capital Employed (Equity 215.9m + L.T.Debt 20.0m))
RoIC = -13.82% (negative operating profit) (NOPAT -31.9m / Invested Capital 230.9m)
WACC = 13.11% (E(2.32b)/V(2.35b) * Re(13.25%) + D(31.3m)/V(2.35b) * Rd(3.64%) * (1-Tc(0.21)))
Discount Rate = 13.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.08%
Fair Price DCF = unknown (Cash Flow -10.1m)
EPS Correlation: 21.61 | EPS CAGR: 3.78% | SUE: -1.53 | # QB: 0
Revenue Correlation: -32.10 | Revenue CAGR: -0.28% | SUE: 1.26 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.05 | Chg30d=+0.007 | Revisions Net=+2 | Analysts=7
EPS next Year (2026-12-31): EPS=0.27 | Chg30d=+0.019 | Revisions Net=+1 | Growth EPS=+24.2% | Growth Revenue=+11.8%